Hildred Capital

General contacts

Investor type

PE / VC

Founded

2018

AUM

$4 000 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe

ESG Focus

Impact investor

Investor profile last updated: 16 August, 2026

Profile

Hildred Capital is a private equity investment firm based in New York City, primarily focused on middle-market companies within the healthcare industry. The firm's unique value proposition lies in its concentrated approach to identifying and investing in healthcare sub-sectors with growth potential. Hildred's team includes seasoned professionals with backgrounds in healthcare business development, operations, marketing, and investment, providing them with the expertise to strategically position portfolio companies for growth.

Hildred Capital invests across various healthcare sub-sectors and employs a strategy centered around operational improvements rather than excessive reliance on debt. The firm makes equity investments ranging from $25 million to $300 million, targeting companies with solid fundamentals in the lower middle market. Hildred Capital boasts an impressive asset under management (AUM) tally of approximately $4 billion, with a diverse portfolio designed to thrive in multiple market conditions.

Notable investments include OrangeTwist, AleraCare, and Pure Healthcare. These companies span a range of healthcare services, from aesthetic treatments and specialty care to an extensive national platform for ambulatory infusion. Hildred's investment strategy is inherently aligned with ESG principles, focusing on sustainable growth and the long-term success of their portfolio companies.

Industry

Medical Devices Healthcare Services Fintech Financial Services Pharmaceuticals AI HealthTech Biotechnology Life Sciences

Hildred Capital Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Hildred Equity Partners III	Private Equity (PE)	Biotechnology Healthcare Services Medical Devices Life Sciences	Series B Late Stage (Series C+)	North America	$5-10 m	$800 M	January 2025
Hildred Equity Partners II	Private Equity (PE)	Biotechnology Healthcare Services Medical Devices Life Sciences	Series B Late Stage (Series C+)	North America	$5-10 m	$363 M	February 2022

Contacts

Name

Title

Social Networks

Andrew Goldman Managing Partner

Managing Partner

a•••@•••

Rob Healy Operating Partner

Operating Partner

r•••@•••

Upgrade to see contacts

u4jSC6qQlImGZhfJ u4jSC6qQlImGZhfJ

u4jSC6qQlImGZhfJ

[email protected]

u4jSC6qQlImGZhfJ u4jSC6qQlImGZhfJ

u4jSC6qQlImGZhfJ

[email protected]

u4jSC6qQlImGZhfJ u4jSC6qQlImGZhfJ

u4jSC6qQlImGZhfJ

[email protected]

Investment-team contacts for Hildred Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Hildred Capital

Is Hildred Capital a venture capital or private equity firm?

Hildred Capital is a venture capital and private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Hildred Capital located?

Hildred Capital is located in New York, New York, United States.

When was Hildred Capital founded?

Hildred Capital was founded in 2018.

What sectors and industries does Hildred Capital invest in?

Hildred Capital invests in companies and startups in Medical Devices, Healthcare Services, Fintech, Financial Services, Pharmaceuticals, AI, HealthTech, Biotechnology, Life Sciences.

What is Hildred Capital geographical focus of investments?

Hildred Capital invests in companies and startups in North America, Europe.

At what stages of companies and startups does Hildred Capital typically invest in?

Hildred Capital invests in companies and startups at Series B, Late Stage (Series C+).

What is the usual amount of Hildred Capital investment?

Hildred Capital usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Hildred Capital?

Hildred Capital has around $4 000m assets under management.

When was Hildred Capital last fund created?

Hildred Capital last fund was created/launched in 2025-01-13

Is Hildred Capital impact investor?

Yes, Hildred Capital is impact investor.

What are the contacts of Hildred Capital?

Hildred Capital can be reached through its website hildredcapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Hildred Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Hildred Capital data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Hildred Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Hildred Capital profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.